30 Day Psychedelic Pharmacology Podcast - Day 23 Safety and Toxicology episode artwork

EPISODE · Jan 30, 2025 · 17 MIN

30 Day Psychedelic Pharmacology Podcast - Day 23 Safety and Toxicology

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores the safety and toxicology of psychedelic substances, with a particular focus on MDMA and LSD. The discussion covers key mechanisms of action through the 5HT2A receptor, potential risks like neurotoxicity and serotonin syndrome, and the importance of careful monitoring in clinical settings. The episode delves into how different psychedelics interact with the brain, including their effects on the default mode network and neuroplasticity. Special attention is given to the role of set and setting in psychedelic therapy and the significance of personalized approaches to treatment.

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

NOW PLAYING

30 Day Psychedelic Pharmacology Podcast - Day 23 Safety and Toxicology

0:00 17:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 17 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!